A detailed history of Squarepoint Ops LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 612,897 shares of HRTX stock, worth $655,799. This represents 0.0% of its overall portfolio holdings.

Number of Shares
612,897
Previous 363,700 68.52%
Holding current value
$655,799
Previous $1.27 Million 4.17%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.73 - $3.67 $431,110 - $914,552
249,197 Added 68.52%
612,897 $1.22 Million
Q2 2024

Aug 14, 2024

BUY
$2.32 - $3.86 $663,891 - $1.1 Million
286,160 Added 369.05%
363,700 $1.27 Million
Q1 2024

May 15, 2024

BUY
$1.71 - $3.06 $132,593 - $237,272
77,540 New
77,540 $214,000
Q2 2023

Aug 14, 2023

BUY
$1.11 - $2.88 $149,650 - $388,281
134,820 Added 532.51%
160,138 $185,000
Q1 2023

May 15, 2023

SELL
$1.51 - $3.25 $158,648 - $341,461
-105,065 Reduced 80.58%
25,318 $38,000
Q4 2022

Feb 14, 2023

SELL
$2.25 - $4.67 $173,974 - $361,093
-77,322 Reduced 37.23%
130,383 $325,000
Q3 2022

Nov 14, 2022

BUY
$2.66 - $5.37 $552,495 - $1.12 Million
207,705 New
207,705 $877,000
Q1 2022

May 16, 2022

SELL
$4.63 - $9.94 $342,124 - $734,496
-73,893 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$8.35 - $12.6 $1.48 Million - $2.23 Million
-177,108 Reduced 70.56%
73,893 $675,000
Q3 2021

Nov 15, 2021

BUY
$10.13 - $15.0 $396,508 - $587,130
39,142 Added 18.48%
251,001 $2.68 Million
Q2 2021

Aug 16, 2021

BUY
$13.27 - $18.48 $810,982 - $1.13 Million
61,114 Added 40.54%
211,859 $3.29 Million
Q1 2021

May 17, 2021

BUY
$14.49 - $20.72 $2.18 Million - $3.12 Million
150,745 New
150,745 $2.44 Million
Q4 2020

Feb 16, 2021

SELL
$14.61 - $22.14 $319,170 - $483,670
-21,846 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$13.67 - $17.77 $298,634 - $388,203
21,846 New
21,846 $324,000
Q2 2020

Aug 14, 2020

SELL
$10.89 - $21.47 $2.3 Million - $4.54 Million
-211,531 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$10.23 - $24.56 $1.35 Million - $3.24 Million
131,851 Added 165.48%
211,531 $2.48 Million
Q4 2019

Feb 14, 2020

BUY
$17.42 - $26.61 $1.39 Million - $2.12 Million
79,680 New
79,680 $1.87 Million
Q3 2019

Nov 14, 2019

SELL
$16.36 - $21.39 $1.15 Million - $1.51 Million
-70,381 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$16.93 - $26.22 $118,916 - $184,169
-7,024 Reduced 9.07%
70,381 $1.31 Million
Q1 2019

May 15, 2019

SELL
$23.15 - $28.34 $652,343 - $798,592
-28,179 Reduced 26.69%
77,405 $1.89 Million
Q4 2018

Feb 14, 2019

BUY
$22.03 - $32.01 $601,925 - $874,609
27,323 Added 34.91%
105,584 $2.74 Million
Q3 2018

Nov 14, 2018

BUY
$30.0 - $40.85 $883,830 - $1.2 Million
29,461 Added 60.37%
78,261 $2.48 Million
Q2 2018

Aug 14, 2018

BUY
$26.4 - $42.0 $660,000 - $1.05 Million
25,000 Added 105.04%
48,800 $1.9 Million
Q1 2018

May 15, 2018

SELL
$18.43 - $28.8 $1.62 Million - $2.53 Million
-87,784 Reduced 78.67%
23,800 $657,000
Q4 2017

Feb 14, 2018

BUY
$14.8 - $18.85 $1.14 Million - $1.45 Million
76,974 Added 222.4%
111,584 $2.02 Million
Q3 2017

Nov 14, 2017

BUY
$14.65 - $16.85 $507,036 - $583,178
34,610
34,610 $559,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $127M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.